Brian Grossman told jurors in the criminal fraud trial of Elizabeth Holmes about the numerous inquiries his hedge fund made, in contrast to other investors in the blood-testing startup.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
